Abstract
Plasma levels of high-density lipoprotein (HDL) are strongly and inversely correlated with atherosclerotic cardiovascular diseases. However, it is becoming clear that a functional HDL is a more desirable target than simply increasing HDL-cholesterol levels. The best known antiatherogenic function of HDL particles relates to their ability to promote reverse cholesterol transport from peripheral cells. However, HDL also possesses antioxidant, anti-inflammatory, and antithrombotic effects. This review focuses on the state of knowledge regarding assays of HDL heterogeneity and function and their relationship to cardiovascular diseases.
Copyright © 2012 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
ATP Binding Cassette Transporter 1
-
ATP-Binding Cassette Transporters / metabolism
-
Animals
-
Anticholesteremic Agents / metabolism*
-
Anticholesteremic Agents / pharmacology
-
Antioxidants / metabolism
-
Apolipoprotein A-I / genetics
-
Apolipoprotein A-I / metabolism
-
Aryldialkylphosphatase / genetics
-
Aryldialkylphosphatase / metabolism
-
Biological Transport
-
Cardiovascular Diseases / metabolism
-
Cardiovascular Diseases / pathology
-
Cardiovascular Diseases / prevention & control*
-
Cholesterol / blood
-
Cholesterol / metabolism
-
Homeostasis
-
Humans
-
Hypercholesterolemia / drug therapy
-
Hypercholesterolemia / metabolism
-
Inflammation / metabolism
-
Inflammation / pathology
-
Lipoproteins, HDL / blood*
-
Lipoproteins, HDL / classification
-
Lipoproteins, HDL / metabolism
-
Mice
-
Oxidation-Reduction
Substances
-
APOA1 protein, human
-
ATP Binding Cassette Transporter 1
-
ATP-Binding Cassette Transporters
-
Anticholesteremic Agents
-
Antioxidants
-
Apolipoprotein A-I
-
Lipoproteins, HDL
-
Cholesterol
-
Aryldialkylphosphatase
-
PON1 protein, mouse